Glaxo Smith Kline (BIOC.CA) Reports Year Ended 31/12/2019 Standalone Results
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Currency : EGP
F/S Standalone Period : From 01/01/2019 To 31/12/2019
Net Profit : 110,265,836
F/S Standalone Period : From 01/01/2018 To 31/12/2018
Net Comparative Profit : 37,123,070
Audit Status : Audited
Source : Glaxo Smith Kline
ISIN Code : EGS38171C012
Currency : EGP
F/S Standalone Period : From 01/01/2019 To 31/12/2019
Net Profit : 110,265,836
F/S Standalone Period : From 01/01/2018 To 31/12/2018
Net Comparative Profit : 37,123,070
Audit Status : Audited
Source : Glaxo Smith Kline
Comments